On 2025-05-13, Ensysce Biosciences, Inc. (ENSC) announced earnings per share of $-1.39 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-3.02.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-1.01 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-3.02 | $-1.39 |
| 2025-03-10 | 2024-12-31 | $-2.74 | $-2.90 |
| 2024-11-12 | 2024-09-30 | $-4.50 | $1.05 |
| 2024-08-14 | 2024-06-30 | $-5.85 | $-3.30 |
| 2024-05-10 | 2024-03-31 | $-13.49 | $-8.25 |
| 2024-03-15 | 2023-12-31 | $-12.89 | $-16.94 |
| 2023-11-09 | 2023-09-30 | $-15.89 | $-13.04 |
| 2023-08-11 | 2023-06-30 | $-40.93 | $-14.69 |
| 2023-05-15 | 2023-03-31 | $-208.55 | $-31.18 |
| 2023-03-30 | 2022-12-31 | $-466.15 | $-273.57 |
| 2022-11-14 | 2022-09-30 | $-539.95 | $-923.31 |
| 2022-08-11 | 2022-06-30 | $-755.92 | $-863.91 |
| 2022-05-12 | 2022-03-31 | $-719.93 | $-719.93 |
| 2022-03-31 | 2021-12-31 | $323.97 | $-1619.84 |
| 2021-11-15 | 2021-09-30 | -- | $-2555.74 |
| 2021-08-16 | 2021-06-30 | -- | $-215.98 |
| 2020-08-07 | 2020-06-30 | -- | $1439.86 |
| 2019-08-07 | 2019-06-30 | -- | $-323.97 |
| 2019-05-07 | 2019-03-31 | -- | $-143.99 |
| 2019-03-11 | 2018-12-31 | -- | $-287.97 |
| 2018-11-07 | 2018-09-30 | -- | $-179.98 |
| 2018-08-01 | 2018-06-30 | -- | $-179.98 |
| 2018-05-03 | 2018-03-31 | -- | $-71.99 |